SCHEMBL3714403

SCHEMBL3714403

CC(=O)C1=C(O)C(=O)N(CCc2ccc(-c3ccccc3)cc2)C1c1ccc(Br)cc1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
USP7 Q93009 1/20 0.69
MEN1 O00255 3/20 0.68
KMT2A Q03164 3/20 0.68
TP53 P04637 1/20 0.62
MDM2 Q00987 1/20 0.62
KDM4E B2RXH2 4/20 0.58
ALDH1A1 P00352 5/20 0.57
HPGD P15428 1/20 0.57
ALOX15 P16050 2/20 0.54
LMNA P02545 1/20 0.54
TSHR P16473 2/20 0.53
RXFP1 Q9HBX9 3/20 0.52
ATM Q13315 1/20 0.52
HTT P42858 2/20 0.52
MAPT P10636 1/20 0.52
HSD17B10 Q99714 1/20 0.51
POLB P06746 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.49
CCR1 P32246 1/20 0.48
CCR2 P41597 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3704381 0.99 MEN1 (0.70) USP7MEN1KMT2ATP53MDM2
SCHEMBL3705340 0.93 MEN1 (0.78) USP7MEN1KMT2ATP53MDM2
SCHEMBL3707576 0.92 KDM4E (0.64) USP7MEN1KMT2ATP53MDM2
SCHEMBL3705385 0.92 USP7 (0.79) USP7MEN1KMT2ATP53MDM2
SCHEMBL3709204 0.86 MEN1 (0.74) USP7MEN1KMT2ATP53MDM2
SCHEMBL3707178 0.86 USP7 (0.78) USP7MEN1KMT2ATP53MDM2
SCHEMBL3716480 0.86 USP7 (0.78) USP7MEN1KMT2ATP53MDM2
SCHEMBL3707749 0.86 USP7 (0.71) USP7MEN1KMT2ATP53MDM2
SCHEMBL3709046 0.86 USP7 (0.78) USP7MEN1KMT2ATP53MDM2
SCHEMBL3715641 0.85 MEN1 (0.73) USP7MEN1KMT2ATP53MDM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010081783-A1 NOVEL SPECIFIC INHIBITORS OF UBIQUITIN SPECIFIC PROTEASE 7, THE PHARMACEUTICAL COMPOSITIONS THEREOF AND THEIR THERAPEUTIC APPLICATIONS HYBRIGENICS SA (FR) 2010-07-22 WO claimed
EP-2208725-A1 Novel specific inhibitors of ubiquitin specific protease 7, the pharmaceutical compositions thereof and their therapeutic applications Hybrigenics S.A. (FR) 2010-07-21 EP claimed
US-20220125760-A1 USE OF USP7 INHIBITORS FOR THE TREATMENT OF ACUTE MYELOID LEUKEMIA (AML) UNIVERSITÉ PAUL SABATIER TOULOUSE III (FR) 2022-04-28 US disclosed
WO-2010081783-A1 NOVEL SPECIFIC INHIBITORS OF UBIQUITIN SPECIFIC PROTEASE 7, THE PHARMACEUTICAL COMPOSITIONS THEREOF AND THEIR THERAPEUTIC APPLICATIONS HYBRIGENICS SA (FR) 2010-07-22 WO disclosed
WO-2010081783-A1 NOVEL SPECIFIC INHIBITORS OF UBIQUITIN SPECIFIC PROTEASE 7, THE PHARMACEUTICAL COMPOSITIONS THEREOF AND THEIR THERAPEUTIC APPLICATIONS HYBRIGENICS SA (FR) 2010-07-22 WO disclosed
EP-2208725-A1 Novel specific inhibitors of ubiquitin specific protease 7, the pharmaceutical compositions thereof and their therapeutic applications Hybrigenics S.A. (FR) 2010-07-21 EP disclosed
EP-2208725-A1 Novel specific inhibitors of ubiquitin specific protease 7, the pharmaceutical compositions thereof and their therapeutic applications Hybrigenics S.A. (FR) 2010-07-21 EP disclosed